[1] 庄辉. 乙型肝炎流行病学研究进展[J]. 国外医学流行病学传染病学分册,2004,31(3):133-135. [2] 于乐成. 慢加急性肝衰竭[J]. 肝脏,2007,12(2):135-137. [3] 周先珊,万谟彬. 拉米夫定耐药的慢性乙型肝炎抗病毒治疗[J]. 中华传染病杂志,2007,25(11):700-702. [4] KAMATH PS,KIM WR,Advanced Liver Disease Study Group. The Model for end-stage liver disease(MELD)[J]. Hepatology,2007,45(3):797-805. [5] KAMATH PS,WIESNER RH,MALINCHOC M,et al. A model to predict survival in patients with end stage liver disease[J]. Hepatology,2001 33(2):464-470. [6] 中华医学会传染病与寄生虫病学分会、肝病学分会. 病毒性肝炎防治方案[J]. 中华传染病杂志,2001,19(1):56-62. [7] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊疗指南[J]. 实用肝脏病杂志,2006,9:321-324. [8] LINDH M,HORAL P,DHILLON AP,et al. Hepatitis B virus DNA levels,precoremutations,genotypes and histological activity in chronic hepatitis B[J]. J Viral Hepatol,2000,7(4):258-267. [9] POLSON J,LEE WM,American Association for the Study of Liver Disease. AASLD position paper:the management of acute liver failure[J]. Hepatology,2005,41(5):1179-1197. [10] HOOFNAGLE JH,DOO E,LIANG TJ,et al. Management of hepatitis B:Summary of a clinical research worship[J]. Hepatology,2007,45:1056-1075. [11] 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南[J]. 实用肝脏病杂志,2006,9:8-18. |